Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

for a total of 12 weeks, prophylactic heparin therapy during hospitalization followed by prophylactic oral anticoagulation with apixaban

during hospitalization prophylactic heparin therapy followed by management without prophylactic anticoagulation.

CBC, reticulocytes, haptoglobin, LDH, bilirubin